PubMed Health⌕ Search

Biomedical subjects

Jonathan M White

Publications and source records attributed to Jonathan M White.

At least 19 recordsLinked to original sources
PubMed2006

Proton-transfer and non-transfer in compounds of quinoline and quinaldic acid with L-tartaric acid.

The structures of two compounds of L-tartaric acid with quinoline, viz. the proton-transfer compound quinolinium hydrogen (2R,3R)-tartrate monohydrate, C9H8N+.C4H5O6-.H2O, (I), and the anhydrous non-proton-transfer adduct with quinaldic acid, bis(quinolinium-2-carboxylate) (2R,3R)-tartaric acid, 2C10H7NO2.C4H6O6, (II), have been determined at 130 K. Compound (I) has a three-dimensional honeycomb substructure formed from head-to-tail hydrogen-bonded hydrogen tartrate anions and water molecules. The stacks of pi-bonded quinolinium cations are accommodated within the channels and are hydrogen bonded to it peripherally. Compound (II) has a two-dimensional network structure based on pseudo-centrosymmetric head-to-tail hydrogen-bonded cyclic dimers comprising zwitterionic quinaldic acid species which are interlinked by tartaric acid molecules.

Journal Article↗
PubMed2006

New bimetallic compounds based on the bis(thiosemicarbazonato) motif.

Zinc and copper bis(thiosemicarbazonato) complexes containing more than one metal centre have been prepared with a view to examining their application for molecular imaging. The zinc complexes are fluorescent with excitation and emission at relatively long wavelengths. The dinuclear copper complex undergoes two sequential, quasi-reversible reductions.

Crystallography, X-Ray↗
PubMed2006

Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues.

The design and synthesis of a small library of 8-amidoflavone, 8-sulfonamidoflavone, 8-amido-7-hydroxyflavone, and heterocyclic analogues of flavopiridol is reported. The potential activity of these compounds as kinase inhibitors was evaluated by cytotoxicity studies in MCF-7 and ID-8 cancer cell lines and inhibition of CDK2-Cyclin A enzyme activity in vitro. The antiproliferative and CDK2-Cyclin A inhibitory activity of these analogues was significantly lower than the activity of flavopiridol. Molecular docking simulations were carried out and these studies suggested a different binding orientation inside the CDK2 binding pocket for these analogues compared to flavopiridol.

Adenosine Triphosphate↗
PubMed2006

Receptor-mediated DNA-targeted photoimmunotherapy.

We show the efficacy of a therapeutic strategy that combines the potency of a DNA-binding photosensitizer, UV(A)Sens, with the tumor-targeting potential of receptor-mediated endocytosis. The photosensitizer is an iodinated bibenzimidazole, which, when bound in the minor groove of DNA and excited by UV(A) irradiation, induces cytotoxic lesions attributed to a radical species resulting from photodehalogenation. Although reminiscent of photochemotherapy using psoralens and UV(A) irradiation, an established treatment modality in dermatology particularly for the treatment of psoriasis and cutaneous T-cell lymphoma, a critical difference is the extreme photopotency of the iodinated bibenzimidazole, approximately 1,000-fold that of psoralens. This feature prompted consideration of combination with the specificity of receptor-mediated targeting. Using two in vitro model systems, we show the UV(A) cytotoxicity of iodo ligand/protein conjugates, implying binding of the conjugate to cell receptors, internalization, and degradation of the conjugate-receptor complex, with release and translocation of the ligand to nuclear DNA. For ligand-transferrin conjugates, phototoxicity was inhibited by coincubation with excess native transferrin. Receptor-mediated UV(A)-induced cytotoxicity was also shown with the iodo ligand conjugate of an anti-human epidermal growth factor receptor monoclonal antibody, exemplifying the potential application of the strategy to other cancer-specific targets to thus improve the specificity of phototherapy of superficial lesions and for extracorporeal treatments.

Animals↗
PubMed2006

Mixed dicationic and monocationic benzidine species in the proton-transfer compound of benzidine with 3,5-dinitrosalicylic acid.

The crystal structure of the proton-transfer compound of 1,1'-biphenyl-4,4'-diamine (benzidine) with 3,5-dinitrosalicylic acid, viz. 1,1'-biphenyl-4,4'-diaminium bis(4'-amino-1,1'-biphenyl-4-aminium) tetrakis(2-carboxy-4,6-dinitrophenolate) ethanol disolvate, C(12)H(14)N(2)(2+)x2C(12)H(13)N(2)(+)x4C(7)H(3)N(2)O(7)(-)x2C(2)H(6)O, shows the presence of both diprotonated and monoprotonated benzidine cations. The diprotonated species lie across crystallographic inversion centres in the unit cell, while the monoprotonated species occupy general sites. All amine H atoms participate in hydrogen bonding with carboxyl, phenolate and nitro O-atom acceptors of the salicylate anions, which also participate in hydrogen bonding with the disordered ethanol solvent molecules. Significant inter-ring anion-anion and anion-monocation pi-pi interactions are also present, giving a three-dimensional framework structure.

Journal Article↗
PubMed2006

Brucine salts of L-alpha-hydroxy acids: brucinium hydrogen (S)-malate pentahydrate and anhydrous brucinium hydrogen (2R,3R)-tartrate at 130 K.

The structures of two brucinium (2,3-dimethoxy-10-oxostrychnidinium) salts of the alpha-hydroxy acids L-malic acid and L-tartaric acid, namely brucinium hydrogen (S)-malate pentahydrate, C23H27N2O4+.C4H5O5-.5H2O, (I), and anhydrous brucinium hydrogen (2R,3R)-tartrate, C23H27N2O4+.C4H5O6-,(II), have been determined at 130 K. Compound (I) has two brucinium cations, two hydrogen malate anions and ten water molecules of solvation in the asymmetric unit, and forms an extensively hydrogen-bonded three-dimensional framework structure. In compound (II), the brucinium cations form the common undulating brucine sheet substructures, which accommodate parallel chains of head-to-tail hydrogen-bonded tartrate anion species in the interstitial cavities.

Crystallography, X-Ray↗
PubMed2006

Pi-acid/pi-base carbonyloxomolybdenum(IV) complexes and their oxomolybdenum(VI/IV) precursors.

Brown TpiPrMoO(SR)(CO) (TpiPr = hydrotris(3-isopropylpyrazol-1-yl)borate; R = Et, iPr, Ph, p-tol, Bz) are formed when TpiPrMoO(SR)(NCMe) react with CO gas in toluene. The carbonyloxomolybdenum(IV) complexes exhibit nu(CO) and nu(Mo=O) IR bands at ca. 2025 and 935 cm(-1), respectively, and NMR spectra indicative of C(1) symmetry, with delta(C)(CO) ca. 250. The crystal structure of TpiPrMoO(SiPr)(CO), the first for a mononuclear carbonyloxomolybdenum complex, revealed a distorted octahedral geometry, with d(Mo=O) = 1.683(3) A, d(Mo-C) = 2.043(5) A, and angle(O=Mo-C) = 90.87(16) degrees . The blue-green acetonitrile precursors are generated by reacting cis-TpiPrMoO2(SR) with PPh3; they are unstable, display a single nu(Mo=O) IR band at ca. 950 cm(-1), and exhibit NMR spectra consistent with C1 symmetry. Red-brown cis-TpiPrMoO2(SR) (R = as above and tBu) are formed by metathesis of TpiPrMoO2Cl and HSR/NEt3 in dichloromethane. The complexes exhibit strong nu(MoO2) IR bands at ca. 925 and 895 cm(-1), and NMR spectra indicative of Cs symmetry; the isopropyl, p-tolyl, and benzyl derivatives possess distorted octahedral geometries, with d(Mo=O)(av) = 1.698 A and angle(MoO(2))(av) = 103.5 degrees.

Journal Article↗
PubMed2006

Paramagnetic active site models for the molybdenum-copper carbon monoxide dehydrogenase.

New paramagnetic, heterobimetallic Mo/Cu complexes featuring the Mo(=O)(mu-S)Cu core of O. carboxidovorans carbon monoxide dehydrogenase have been synthesized and structurally and spectroscopically characterized. The complexes exhibit EPR spectra (left graphic) indicative of extensive electron delocalization across the Mo-S-Cu core, in agreement with computational studies identifying the singly-occupied molecular orbital (right graphic).

Aldehyde Oxidoreductases↗
PubMed2006

Copper complexes of thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands: a new versatile potential bifunctional chelator for copper radiopharmaceuticals.

Two new thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands have been synthesized. Copper(II) and copper(I) complexes of the ligands have been prepared and characterized by X-ray crystallography. Cyclic voltammetry measurements show that the copper(II) complexes undergo quasi-reversible reductions at biologically accessible potentials. One of the ligands, bearing a pendant carboxylate arm, has been conjugated to N-alpha-(tert-butoxycarbonyl)-L-lysine.

Chelating Agents↗
PubMed2006

Models for the molybdenum hydroxylases: synthesis, characterization and reactivity of cis-oxosulfido-Mo(VI) complexes.

Atom transfer reactions have been employed to convert Tp(i)(Pr)MoO(2)(OAr) into monomeric cis-oxosulfido-Mo(VI) and dimeric mu-disulfido-Mo(V) species, [Tp(i)(Pr)MoOS(OAr)](n)() (Tp(i)(Pr) = hydrotris(3-isopropylpyrazol-1-yl)borate; OAr = phenolate or naphtholate derivative; n = 1 and 2, respectively). Dark red, monomeric Tp(i)(Pr)MoOS(OAr) complexes contain distorted octahedral cis-oxosulfido-Mo(VI) centers, with d(Mo=O) = 1.692(5) A, d(Mo=S) = 2.132(2) A, and angle(O=Mo=S) = 103.68(16) degrees for the 2-sec-butylphenolate derivative. Dark red-purple, dimeric [Tp(i)(Pr)MoOS(OAr)](2) complexes undergo S-S bond cleavage forming monomeric oxosulfido-Mo(VI) species in solution. In the solid state, the 3,5-di-tert-butylphenolate derivative exhibits a centrosymmetric structure, with distorted octahedral anti oxo-Mo(V) centers bridged by a disulfido-kappaS,kappaS' ligand. Hydrolysis of the oxosulfido-Mo(VI) complexes results in the formation of [Tp(i)(Pr)MoO](2)(mu-S(2))(mu-O). In anaerobic solutions, certain oxosulfido-Mo(VI) complexes convert to molybdenyl complexes bearing bidentate 2-mercaptophenolate or related naphtholate ligands formed via intramolecular attack of the sulfido ligand on a coligand C-H group. The oxosulfido-Mo(VI) complexes serve as precursors to biologically relevant Mo(V) and heterobimetallic MoO(mu-S)Cu species and undergo a range of biomimetic reactions.

Mixed Function Oxygenases↗
PubMed2005

Preparation of 2,3-dihydroselenolo[2,3-b]pyridines and related compounds by free-radical means.

Photolysis of the thiohydroximate ester derivative 21 of 2-carboethoxy-2-(2-(benzylseleno)pyridin-3-yl)tridecylcarboxylic acid (20) affords 2-dodecyl-2-carboethoxy-2,3-dihydroselenolo[2,3-b]pyridine (22) in 89% yield in a process presumably involving intramolecular homolytic substitution by a tertiary alkyl radical at selenium with loss of a benzyl radical. Alternatively, rearrangement of O-(omega-haloalkyl)esters 34 of 2-carboethoxy-N-hydroxypyridine-2-selone affords azonianaphthalenium halides 37 in 79% yield.

Esters↗
PubMed2005

Hydrogen bonding in brucinium dihydrogen citrate trihydrate at 130 K.

The structure of brucinium dihydrogen citrate trihydrate (systematic name: 2,3-dimethoxy-10-oxostrychnidinium dihydrogen citrate trihydrate), C(23)H(27)N(2)O(4)(+).C(6)H(7)O(7)(-).3H(2)O, has been determined at 130 K. The crystallographic asymmetric unit comprises two brucinium cations, two dihydrogen citrate anions and six water molecules of solvation. The two citrate anions, which are conformationally dissimilar, associate through extensive hydrogen-bonding interactions with the common undulating brucinium cation layer substructures and the water molecules, forming a three-dimensional framework polymer.

Journal Article↗
PubMed2005

Synthesis and characterisation of second-generation metallodithiolene complexes of the type [Tp*ME(dithiolene)](M=Mo, W; E=O, S) and a novel 'organoscorpionate' complex of tungsten.

Paramagnetic, chalcogenido-M(v) dithiolene complexes, [Tp*ME{S2C2(CO2Me)2}][M=Mo, E=O, S; M=W, E=O, S; Tp*=hydrotris(3,5-dimethylpyrazol-1-yl)borate] are generated in the reactions of dimethyl acetylenedicarboxylate (DMAC) and the sulfur-rich complexes NEt4[Tp*MoS(S4)] and NEt4[Tp*WS3]; the oxo complexes result from hydrolysis of the initial sulfido products. As well, a novel 'organoscorpionate' complex, [W{S2C2(CO2Me)2}{SC2(CO2Me)2-Tp*}], has been isolated from the reactions of NEt4[Tp*WS3] with excess DMAC. Complexes , and have been isolated and characterised by microanalytical, mass spectrometric, spectroscopic and (for and) X-ray crystallographic techniques. Complexes and have been partially characterised by mass spectrometry and IR and EPR spectroscopy. Six-coordinate, distorted-octahedral contains a terminal sulfido ligand (W=S=2.108(3)A), a bidentate dithiolene ligand (S-Cav=1.758 A, C=C=1.332(10)A) and a fac-tridentate Tp* ligand. Seven-coordinate contains a planar, bidentate dithiolene ligand (S-Cav=1.746 A, C=C=1.359(5)A) and a novel pentadentate 'organoscorpionate' ligand formed by the melding of DMAC, sulfido and trispyrazolylborate units. The latter is coordinated through two pyrazolyl N atoms (kappa2-N,N') and a tridentate kappa3-S,C,C' unit appended to N-beta of the third (uncoordinated) pyrazolyl group. The second-generation [Tp*ME(dithiolene)] complexes represent a refinement on first-generation [Tp*ME(arene-1,2-dithiolate)] complexes and their synthesis affords an opportunity to compare and contrast the electronic structures of true vs. pseudo-dithiolene ligands in otherwise analogous complexes.

Journal Article↗
PubMed2005

The proton-transfer compounds of strychnine with achiral salicylic acids: strychninium 3,5-dinitrosalicylate and the strychninium 5-nitrosalicylate bis(5-nitrosalicylic acid) adduct.

In the crystal structures of the proton-transfer compounds of strychnine with 3,5-dinitrosalicylic acid, namely strychninium 3,5-dinitrosalicylate, C21H23N2O2+.C7H3N2O7-, (I), and 5-nitrosalicylic acid, namely strychninium-5-nitrosalicylate-5-nitrosalicylic acid (1/1/2), C21H23N2O2+.C7H4NO5-.2C7H5NO5, (II), protonation of one of the N atoms of the strychnine molecule occurs and this group is subsequently involved in intermolecular hydrogen-bonding interactions. In (I), this is four-centred, the primary being with an adjacent strychninium carbonyl O-atom acceptor in a side-to-side interaction giving linear chains. Other interactions are with the phenolate and nitro O-atom acceptors of the anionic species, resulting in a one-dimensional polymer structure. In (II), the N+-H interaction is three-centred, the hydrogen bonding involving carboxyl O-atom acceptors of the anion and both acid adduct species, giving unique discrete hetero-tetramer units. The structure of (II) also features pi-bonding interactions between the two acid adduct molecules.

Journal Article↗
PubMed2005

Enantiospecific synthesis of (-)-trachyspic acid.

The enantiospecific synthesis of (-)-trachyspic acid () is presented. This has allowed for the assignment of the absolute configuration of natural (+)-trachyspic acid as 3S,4S,6S.

Crystallography, X-Ray↗
PubMed2005

Synthesis of the putative structure of tridachiahydropyrone.

[reaction: see text] A short total synthesis of the putative structure of the marine natural product tridachiahydropyrone as a single enantiomer is described. Novel steps include a cuprate addition and cyclization to form a cyclohexanone ring and formation of the bicyclic pyrone with P(2)O(5) on Celite. The spectroscopic data obtained for compound 1 do not match those reported for tridachiahydropyrone; therefore, revision of the assigned natural product structure is warranted.

Animals↗